Skip to main content
. 2016 Jun 24;4(2):191–197. doi: 10.1002/mdc3.12382

Figure 1.

Figure 1

A: The percentage of patients who screened positive for depressive symptoms at the initial visit (left) and considering all clinic visits (right). Post‐hoc analysis indicates differences between subgroups (shown with respective P values). B: The severity of depressive symptoms across different parkinsonian disorders at the initial visit. PD, Parkinson's disease; CBD, corticobasal degeneration; DLB, dementia with Lewy bodies; MSA, multiple system atrophy; PSP, progressive supranuclear palsy.